Medical Oncology

, Volume 11, Issue 1, pp 1–6

Growth factors and hematopoietic recovery

  • Subhash C. Gulati
  • Ravi Gopal
  • Judith B. Prowda
  • Stanislov Spanik
  • Maneesh Jain
  • Ajay Gopal
Review Article

DOI: 10.1007/BF02990084

Cite this article as:
Gulati, S.C., Gopal, R., Prowda, J.B. et al. Med Oncol (1994) 11: 1. doi:10.1007/BF02990084

Abstract

Availability of hematopoietic growth factors (GC-SF, GM-CSF, erythropoietin,etc.) has started a new arena of dose-intensification. The use of such growth factors has resulted in faster hematopoietic recovery of cancer patients and now offers several new treatment modifications. These include: (1)dose-intensification without hematopoietic stem cell support, (2) speedier hematopoetic recovery after hematoablative therapy and stem cell transplantation (allogeneic or autologous); (3) use of combination of growth factors, and (4) improvement in the delivery of anti-microbial drugs which are toxic towards hematopoietic cells (Gancyclovir, Bactrim,etc.). The above treatment strategies are under active clinical trials and can provide improved, cost-effective methods of treating patients with cancer.

Key Words

Growth factors hematopoietic recovery 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Humana Press Inc. 1994

Authors and Affiliations

  • Subhash C. Gulati
    • 1
  • Ravi Gopal
    • 1
  • Judith B. Prowda
    • 1
  • Stanislov Spanik
    • 1
  • Maneesh Jain
    • 1
  • Ajay Gopal
    • 1
  1. 1.Division of Hematology OncologyCornell University Medical CollegeNew York

Personalised recommendations